Market Overview:
The global cardiopulmonary stress testing systems market is expected to grow at a CAGR of 5.8% from 2018 to 2030. The growth in the market can be attributed to the increasing prevalence of cardiovascular diseases, technological advancements in cardiopulmonary stress testing systems, and rising demand for minimally invasive procedures. Based on type, the global cardiopulmonary stress testing systems market is segmented into cardiopulmonary exercise testing (CPET) systems, stress ECG, pulse oximeters, stress blood pressure monitors, and single-photon emission computed tomography (SPECT). The CPET system segment is expected to grow at a CAGR of 6.1% from 2018 to 2030 due to its ability to provide comprehensive information about a patient’s heart health. Based on application, the global cardiopulmonary stress testing systems market is segmented into hospitals, specialty clinics/cardiology clinics, ambulatory surgical centers (ASCs), and diagnostic centers.
Product Definition:
A cardiopulmonary stress test system is a device used to measure the response of the heart and lungs to increased levels of activity or stress. The system consists of a treadmill or bicycle ergometer, along with sensors that monitor heart rate, blood pressure, and lung function. Cardiopulmonary stress testing systems are used to diagnose cardiovascular disease and assess the risk of cardiac events in patients.
Cardiopulmonary Exercise Testing (CPET) Systems:
CPET is a test that measures the ability of the heart and lungs to pump blood. CPET systems are used for testing athletes who have suffered an injury or during surgeries where it is important to measure cardiac output.
CPET system works by pumping air or oxygen-poor air into the patient's body, which causes a rise in arterial pressure followed by venous return under control of cardiopulmonary bypass machine.
Stress ECG:
Stress ECG is a diagnostic tool that helps in analyzing the response of the heart to physical or mental stress. It’s an invasive procedure wherein small holes are made on the skin and then attached electrodes are inserted which records electrical activities of heart for few minutes. The recorded data is analyzed by computer software which gives a clear picture about whether or not there will be any problem with functioning of heart muscles.
Application Insights:
The market is segmented into hospitals, specialty clinics/cardiology clinics, and ambulatory surgical centers. The hospitals segment dominated the global market in 2017 owing to factors such as increasing prevalence of cardiac diseases and rising geriatric population with cardiac disorders. According to a study published by the CDC in December 2016, around 1 in every 3 deaths occur due to cardiovascular disease (CVD) globally. Furthermore, according to WHO CVD statistics 2018 published on 11 January 2019, around 2/3rds of all deaths are caused by CVD worldwide. Thus focusing on improving healthcare infrastructure and availability would be one of the key strategies adopted by various governments across the world for reducing mortality associated with Cardiac Diseases & Disorders (CD). This is expected to fuel demand over forecast period.
Regional Analysis:
North America dominated the global market in 2017. This can be attributed to the presence of key players, high adoption rate of new technologies, and favorable reimbursement policies. The U.S., which is at the forefront of this region, has a well-developed healthcare infrastructure that makes it one of the most attractive markets for industry participants to invest in over here.
Asia Pacific is expected to register significant growth during the forecast period owing to increasing government initiatives for promoting cardiovascular health among its populace and rising disposable income levels that are enabling people there access better healthcare facilities & products than ever before. Moreover, growing awareness regarding stress testing procedures will also spur demand during this period as these tests are typically performed only after a person suffers from symptoms suggestive of cardiac problems such as chest pain or shortness of breath (dyspnea).
Growth Factors:
- Increasing incidence of cardiovascular diseases (CVDs)
- Growing geriatric population
- Rising awareness about the benefits of early diagnosis and treatment of CVDs
- Technological advancements in cardiopulmonary stress testing systems
- Increasing demand for minimally invasive procedures
Scope Of The Report
Report Attributes
Report Details
Report Title
Cardiopulmonary Stress Testing Systems Market Research Report
By Type
Cardiopulmonary Exercise Testing (CPET) Systems, Stress ECG, Pulse Oximeters, Stress Blood Pressure Monitors, Single-Photon Emission Computed Tomography (SPECT)
By Application
Hospitals, Specialty Clinics/Cardiology Clinics, Ambulatory Surgical Centers, Diagnostic Centers
By Companies
BD, GE Healthcare, Philips Healthcare, Spacelabs Healthcare, Cardinal Health, Fukuda Denshi, MGC Diagnostic, Mortara Instrument, Nihon Kohden, Schiller, BD, Hill-Rom
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
213
Number of Tables & Figures
150
Customization Available
Yes, the report can be customized as per your need.
Global Cardiopulmonary Stress Testing Systems Market Report Segments:
The global Cardiopulmonary Stress Testing Systems market is segmented on the basis of:
Types
Cardiopulmonary Exercise Testing (CPET) Systems, Stress ECG, Pulse Oximeters, Stress Blood Pressure Monitors, Single-Photon Emission Computed Tomography (SPECT)
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals, Specialty Clinics/Cardiology Clinics, Ambulatory Surgical Centers, Diagnostic Centers
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- BD
- GE Healthcare
- Philips Healthcare
- Spacelabs Healthcare
- Cardinal Health
- Fukuda Denshi
- MGC Diagnostic
- Mortara Instrument
- Nihon Kohden
- Schiller
- BD
- Hill-Rom
Highlights of The Cardiopulmonary Stress Testing Systems Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Cardiopulmonary Exercise Testing (CPET) Systems
- Stress ECG
- Pulse Oximeters
- Stress Blood Pressure Monitors
- Single-Photon Emission Computed Tomography (SPECT)
- By Application:
- Hospitals
- Specialty Clinics/Cardiology Clinics
- Ambulatory Surgical Centers
- Diagnostic Centers
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Cardiopulmonary Stress Testing Systems Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Cardiopulmonary stress testing systems are medical devices that measure the heart and lungs' ability to function under pressure. This information can help doctors diagnose and treat conditions such as heart disease, lung cancer, and asthma.
Some of the major companies in the cardiopulmonary stress testing systems market are BD, GE Healthcare, Philips Healthcare, Spacelabs Healthcare, Cardinal Health, Fukuda Denshi, MGC Diagnostic, Mortara Instrument, Nihon Kohden, Schiller, BD, Hill-Rom.
The cardiopulmonary stress testing systems market is expected to grow at a compound annual growth rate of 5.8%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Cardiopulmonary Stress Testing Systems Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Cardiopulmonary Stress Testing Systems Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Cardiopulmonary Stress Testing Systems Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Cardiopulmonary Stress Testing Systems Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Cardiopulmonary Stress Testing Systems Market Size & Forecast, 2018-2028
4.5.1 Cardiopulmonary Stress Testing Systems Market Size and Y-o-Y Growth
4.5.2 Cardiopulmonary Stress Testing Systems Market Absolute $ Opportunity
Chapter 5 Global Cardiopulmonary Stress Testing Systems Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Cardiopulmonary Stress Testing Systems Market Size Forecast by Type
5.2.1 Cardiopulmonary Exercise Testing (CPET) Systems
5.2.2 Stress ECG
5.2.3 Pulse Oximeters
5.2.4 Stress Blood Pressure Monitors
5.2.5 Single-Photon Emission Computed Tomography (SPECT)
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Cardiopulmonary Stress Testing Systems Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Cardiopulmonary Stress Testing Systems Market Size Forecast by Applications
6.2.1 Hospitals
6.2.2 Specialty Clinics/Cardiology Clinics
6.2.3 Ambulatory Surgical Centers
6.2.4 Diagnostic Centers
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Cardiopulmonary Stress Testing Systems Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Cardiopulmonary Stress Testing Systems Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Cardiopulmonary Stress Testing Systems Analysis and Forecast
9.1 Introduction
9.2 North America Cardiopulmonary Stress Testing Systems Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Cardiopulmonary Stress Testing Systems Market Size Forecast by Type
9.6.1 Cardiopulmonary Exercise Testing (CPET) Systems
9.6.2 Stress ECG
9.6.3 Pulse Oximeters
9.6.4 Stress Blood Pressure Monitors
9.6.5 Single-Photon Emission Computed Tomography (SPECT)
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Cardiopulmonary Stress Testing Systems Market Size Forecast by Applications
9.10.1 Hospitals
9.10.2 Specialty Clinics/Cardiology Clinics
9.10.3 Ambulatory Surgical Centers
9.10.4 Diagnostic Centers
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Cardiopulmonary Stress Testing Systems Analysis and Forecast
10.1 Introduction
10.2 Europe Cardiopulmonary Stress Testing Systems Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Cardiopulmonary Stress Testing Systems Market Size Forecast by Type
10.6.1 Cardiopulmonary Exercise Testing (CPET) Systems
10.6.2 Stress ECG
10.6.3 Pulse Oximeters
10.6.4 Stress Blood Pressure Monitors
10.6.5 Single-Photon Emission Computed Tomography (SPECT)
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Cardiopulmonary Stress Testing Systems Market Size Forecast by Applications
10.10.1 Hospitals
10.10.2 Specialty Clinics/Cardiology Clinics
10.10.3 Ambulatory Surgical Centers
10.10.4 Diagnostic Centers
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Cardiopulmonary Stress Testing Systems Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Cardiopulmonary Stress Testing Systems Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Cardiopulmonary Stress Testing Systems Market Size Forecast by Type
11.6.1 Cardiopulmonary Exercise Testing (CPET) Systems
11.6.2 Stress ECG
11.6.3 Pulse Oximeters
11.6.4 Stress Blood Pressure Monitors
11.6.5 Single-Photon Emission Computed Tomography (SPECT)
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Cardiopulmonary Stress Testing Systems Market Size Forecast by Applications
11.10.1 Hospitals
11.10.2 Specialty Clinics/Cardiology Clinics
11.10.3 Ambulatory Surgical Centers
11.10.4 Diagnostic Centers
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Cardiopulmonary Stress Testing Systems Analysis and Forecast
12.1 Introduction
12.2 Latin America Cardiopulmonary Stress Testing Systems Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Cardiopulmonary Stress Testing Systems Market Size Forecast by Type
12.6.1 Cardiopulmonary Exercise Testing (CPET) Systems
12.6.2 Stress ECG
12.6.3 Pulse Oximeters
12.6.4 Stress Blood Pressure Monitors
12.6.5 Single-Photon Emission Computed Tomography (SPECT)
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Cardiopulmonary Stress Testing Systems Market Size Forecast by Applications
12.10.1 Hospitals
12.10.2 Specialty Clinics/Cardiology Clinics
12.10.3 Ambulatory Surgical Centers
12.10.4 Diagnostic Centers
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Cardiopulmonary Stress Testing Systems Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Cardiopulmonary Stress Testing Systems Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Cardiopulmonary Stress Testing Systems Market Size Forecast by Type
13.6.1 Cardiopulmonary Exercise Testing (CPET) Systems
13.6.2 Stress ECG
13.6.3 Pulse Oximeters
13.6.4 Stress Blood Pressure Monitors
13.6.5 Single-Photon Emission Computed Tomography (SPECT)
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Cardiopulmonary Stress Testing Systems Market Size Forecast by Applications
13.10.1 Hospitals
13.10.2 Specialty Clinics/Cardiology Clinics
13.10.3 Ambulatory Surgical Centers
13.10.4 Diagnostic Centers
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Cardiopulmonary Stress Testing Systems Market: Competitive Dashboard
14.2 Global Cardiopulmonary Stress Testing Systems Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 BD
14.3.2 GE Healthcare
14.3.3 Philips Healthcare
14.3.4 Spacelabs Healthcare
14.3.5 Cardinal Health
14.3.6 Fukuda Denshi
14.3.7 MGC Diagnostic
14.3.8 Mortara Instrument
14.3.9 Nihon Kohden
14.3.10 Schiller
14.3.11 BD
14.3.12 Hill-Rom
